{
    "Trade/Device Name(s)": [
        "ABX PENTRA HbA1c WB",
        "ABX PENTRA HbA1c WB Cal",
        "ABX PENTRA HbA1c WB Control",
        "ABX PENTRA HbA1c WB Hemolysis Reagent"
    ],
    "Submitter Information": "Horiba ABX",
    "510(k) Number": "K073309",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031380",
        "K955087",
        "K951361"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIX",
        "JJY",
        "GGK"
    ],
    "Summary Letter Date": "September 30, 2008",
    "Summary Letter Received Date": "October 2, 2008",
    "Submission Date": "June 24, 2008",
    "Regulation Number(s)": [
        "21CFR864.7470",
        "21CFR862.1150",
        "21CFR862.1660",
        "21CFR862.8540"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Calibrator",
        "Quality control material (assayed)",
        "Red cell lysing product"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Hemolysate"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ABX PENTRA 400 Clinical Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay",
        "Turbidimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control",
        "Hemolysis reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Horiba ABX PENTRA HbA1c reagent, calibrator, control, and hemolysis reagent for quantitative measurement of hemoglobin A1c on ABX PENTRA 400 analyzer",
    "Indications for Use Summary": "Quantitative in vitro diagnostic determination of Hemoglobin A1c percentage in human whole blood for diabetes management, intended for use on ABX PENTRA 400 Clinical Chemistry Analyzer",
    "fda_folder": "Hematology"
}